Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
Phase 2 trial data (Jastreboff et al., NEJM, 2023) demonstrated substantial weight reduction participants lost a mean of approximately 24% of body weight over 48 weeks at the highest doses alongside improvements in cardiometabolic markers
If the patient is not comfortable taking the doses at home, they may schedule weekly medication administration in the clinic which will be free of charge
GLP-1 and GIP are both secreted in response to food ingestion
Peak Wellness may not be the best option for patients with complex or serious health conditions or those managing multiple comorbidities
Building on the previously described social influences, two further levels can guide implementation
